Abstract
Purpose
To test the relative importance of anxiety, depression and somatization as correlates of physical health-related quality of life (HRQOL) in several chronic physical disorders.
Methods
In a cross-sectional study of patients with colorectal cancer (N = 162), glaucoma (N = 100), rheumatoid arthritis (N = 168), systemic sclerosis (N = 56) and systemic lupus erythematosus (N = 56), we assessed specific disease severity and used the Symptom Distress Checklist (SCL-90) for psychologic dimensions. Outcome was assessed with the WHO Quality of Life Instrument, Short Form using hierarchical regression to determine independent correlates of HRQOL.
Results
After adjustment for demographic features, stage of cancer and pain (final models), the SCL-90 somatization score was the only psychologic distress covariate significantly correlated to physical HRQOL in all diseases (Betas between −0.33 and −0.49) except in systemic sclerosis and scleroderma, where depression was also a correlate. In glaucoma patients, the SCL-90 somatization score was the only significant covariate for physical HRQOL in the final model.
Conclusions
Since reported number of bodily symptoms is both associated with physical HRQOL and treatable in its own right, our findings suggest a possible new avenue to improve the HRQOL in patients with chronic physical disease. Whether this offers greater benefit than treatments for anxiety and depression needs further research.
Similar content being viewed by others
References
Kroenke, K., Spitzer, R. L., DeGruy, F. V., 3rd, Hahn, S. R., Linzer, M., Williams, J. B., et al. (1997). Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Archives of General Psychiatry, 54(4), 352–358.
Feder, A., Olfson, M., Gameroff, M., Fuentes, M., Shea, S., Lantigua, R. A., et al. (2001). Medically unexplained symptoms in an urban general medicine practice. Psychosomatics, 42(3), 261–268.
Koch, H., van Bokhoven, M. A., ter Riet, G., van der Weijden, T., Dinant, G. J., & Bindels, P. J. (2007). Demographic characteristics and quality of life of patients with unexplained complaints: A descriptive study in general practice. Quality of Life Research, 16(9), 1483–1489.
Jackson, J., Fiddler, M., Kapur, N., Wells, A., Tomenson, B., & Creed, F. (2006). Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. Journal of Psychosomatic Research, 60(4), 357–363.
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2002). The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic Medicine, 64, 258–266.
Barsky, A. J., Orav, E. J., & Bates, D. W. (2005). Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Archives of General Psychiatry, 62, 903–910.
Derogatis, L. R. (1994). SCL-90-R: Administration, scoring, and procedure manual (3rd ed.). Minneapolis, MN: National Computer Systems.
Creed, F., Tomenson, B., Guthrie, E., Ratcliffe, J., Fernandes, L., Read, N., et al. (2008). The relationship between somatization and outcome in patients with severe irritable bowel syndrome. Journal of Psychosomatic Research, 64(6), 613–620.
Skarstein, J., Aass, N., Fosså, S. D., Skovlund, E., & Dahl, A. A. (2000). Anxiety and depression in cancer patients: Relation between the hospital anxiety and depression scale and the European organization for research and treatment of cancer core quality of life questionnaire. Journal of Psychosomatic Research, 49(1), 27–34.
Stark, D., Kiely, M., Smith, A., Velikova, G., House, A., & Selby, P. (2002). Anxiety disorders in cancer patients: Their nature, associations, and relation to quality of life. Journal of Clinical Oncology, 20(14), 3137–3148.
Smith, E. M., Gomm, S. A., & Dickens, C. M. (2003). Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliative Medicine, 17(6), 509–513.
Tsunoda, A., Nakao, K., Hiratsuka, K., Yasuda, N., Shibusawa, M., & Kusano, M. (2005). Anxiety, depression and quality of life in colorectal cancer patients. International Journal of Clinical Oncology, 10(6), 411–417.
Lehto, U. S., Ojanen, M., & Kellokumpu-Lehtinen, P. (2005). Predictors of quality of life in newly diagnosed melanoma and breast cancer patients. Annals of Oncology, 16(5), 805–816.
Chaturvedi, S. K., & Maguire, G. P. (1998). Persistent somatization in cancer: A controlled follow-up study. Journal of Psychosomatic Research, 45(3), 249–256.
Chaturvedi, S. K., Maguire., G. P., & Somashekar, B. S. (2006). Somatization in cancer. International Review of Psychiatry, 18(1), 49–54.
Andritsch, E., Dietmaier, G., Hofmann, G., Zloklikovits, S., & Samonigg, H. (2007). Global quality of life and its potential predictors in breast cancer patients: An exploratory study. Supportive Care in Cancer, 15(1), 21–30.
Altangerel, U., Spaeth, G. L., & Rhee, D. J. (2003). Visual function, disability, and psychological impact of glaucoma. Current Opinion in Ophthalmology, 14(2), 100–105.
Jampel, H. D., Frick, K. D., Janz, N. K., Wren, P. A., Musch, D. C., Rimal, R., et al. (2007). CIGTS study group. Depression and mood indicators in newly diagnosed glaucoma patients. American Journal of Ophthalmology, 144(2), 238–244.
Pappa, C., Hyphantis, T., Pappa, S., Aspiotis, M., Stefaniotou, M., Kitsos, G., et al. (2006). Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment. Journal of Psychosomatic Research, 61(5), 609–617.
Jayawant, S. S., Bhosle, M. J., Anderson, R. T., & Balkrishnan, R. (2007). Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma. Journal of Glaucoma, 16(6), 513–520.
Escalante, A., & Del Rincón, I. (2002). The disablement process in rheumatoid arthritis. Arthritis and Rheumatism, 47(3), 333–342.
Bazzichi, L., Maser, J., Piccinni, A., Rucci, P., Del Debbio, A., Vivarelli, L., et al. (2005). Quality of life in rheumatoid arthritis: Impact of disability and lifetime depressive spectrum symptomatology. Clinical and Experimental Rheumatology, 23(6), 783–788.
Danieli, E., Airo, P., Bettoni, L., Cinquini, M., Antonioli, Ch., Cavazzana, I., et al. (2005). Health-related quality of life measured by the Short Form 36 (SF 36) in systemic sclerosis: Correlations with indexes of disease activity and severity, disability and depressive symptoms. Clinical Rheumatology, 24, 48–54.
Rupp, I., Boshuizen, H. C., Dinant, H. J., Jacobi, C. E., & van den Bos, G. A. (2006). Disability and health-related quality of life among patients with rheumatoid arthritis: Association with radiographic joint damage, disease activity, pain, and depressive symptoms. Scandinavian Journal of Rheumatology, 35(3), 175–181.
Hyphantis, T. N., Tsifetaki, N., Siafaka, V., Voulgari, P. V., Pappa, C., Bai, M., et al. (2007). The impact of psychological functioning upon systemic sclerosis patients’ quality of life. Seminars in Arthritis and Rheumatism, 37, 81–92.
Guthrie, E., Jackson, J., Shaffer, J., Thompson, D., Tomenson, B., & Creed, F. (2002). Psychological disorder and severity inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease. American Journal of Gastroenterology, 97, 1994–1999.
Sainsbury, A., & Heatley, R. V. (2005). Review article: Psychosocial factors in the quality of life of patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 21(5), 499–508.
Vidal, A., Gómez-Gil, E., Sans, M., Portella, M. J., Salamero, M., Piqué, J. M., et al. (2008). Health-related quality of life in inflammatory bowel disease patients: The role of psychopathology and personality. Inflammatory Bowel Disease., 14(7), 977–983.
Hyphantis, T., Tomenson, B., Bai, M., Tsianos, E., Mavreas, V., & Creed, F. (2009). Psychological distress, somatization and defense mechanisms associated with quality of life in inflammatory bowel disease patients. Digestive Diseases and Sciences. doi:10.1007/s10620-009-0762-z.
American Joint Committee on Cancer. AJCC Staging Manual ed 6. (2002). Colon and rectum. Philadelphia: Lippincott- Raven Publishers.
Compton, C. C., Fielding, L. P., Burgart, L. J., et al. (2000). Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement, 1999. Archives of Pathology and Laboratory Medicine, 124(7), 979.
American Rheumatism Association Diagnostic and Therapeutic Committee. (1980). Subcommittee for scleroderma criteria: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis and Rheumatism, 23, 581–590.
Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., et al. (1988). The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism, 31(3), 315–324.
Hochberg, M. C. (1997). Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism, 40(9), 1725.
Aasman, P., & Heijl, A. (1992). Evaluation of methods for automated hemifield analysis in perimetry. Archives of Ophthalmology, 110, 812–819.
Prevoo, M. L., van’t Hof, M. A., Kuper, H. H., et al. (1995). Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longtudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism, 38, 44–48.
Bruce, B., & Fries, J. (2003). The Stanford health assessment questionnaire (HAQ): A review of its history, issues, progress, and documentation. Journal of Rheumatology, 30(1), 167–178.
Committee on Prognosis Studies. (1986). Prognosis studies in SLE: An activity index. Arthritis and Rheumatism, 29(4), 93.
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., & the Committee on Prognosis Studies in SLE. (1992). Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis and Rheumatism, 35, 630–640.
Clements, P., Lachenbruch, P., Siebold, J., White, B., Weiner, S., Martin, R., et al. (1995). Inter and intraobserver variability of total skin thickness score (Modified Rodnan TSS) in systemic sclerosis. Journal of Rheumatology, 22, 1281–1285.
Matucci-Cericic, M., D’ Angelo, S., Denton, C. P., Vlachoyiannopoulos, P., & Silver, R. (2003). Assessment of lung involvement. Clinical and Experimental Rheumatology, 21(29), 19–23.
Clements, P. J., Becvar, R., Drosos, A. A., Ghattas, L., & Gabrielli, A. (2003). Assessment of gastrointestinal involvement. Clinical and Experimental Rheumatology, 21(29), 15–18.
Steen, V. D., Mayes, M. D., & Merkel, P. A. (2003). Assessment of kidney involvement. Clinical and Experimental Rheumatology, 21(29), 29–31.
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373–383.
De Groot, V., Beckerman, H., Lankhorst, G. J., & Bouter, L. M. (2003). How to measure comorbidity. A critical review of available methods. Journal of Clinical Epidemiology, 56, 221–229.
Recklitis, C. J., Licht, I., Ford, J., Oeffinger, K., & Diller, L. (2007). Screening adult survivors of childhood cancer with the distress thermometer: A comparison with the SCL-90-R. Psychooncology, 16(11), 1046–1049.
Parker, J. C., Buckelew, S. P., Smarr, K. L., Buescher, K. L., Beck, N. C., Frank, R. G., et al. (1990). Psychological screening in rheumatoid arthritis. Journal of Rheumatology, 17, 1016–1021.
Donias, S., Karastergiou, A., & Manos, N. (1991). Standardization of the symptom checklist-90-R rating scale in a Greek population (in Greek with English abstract). Psychiatriki, 2, 42–48.
WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychological Medicine, 28(3), 551–558.
Skevington, S. M., Lotfy, M., O’Connell, K. A., & WHOQOL Group. (2004). The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research, 13(2), 299–310.
Taylor, W. J., Myers, J., Simpson, R. T., McPherson, K. M., & Weatherall, M. (2004). Quality of life of people with rheumatoid arthritis as measured by the World Health Organization Quality of Life Instrument, short form (WHOQOL-BREF): Score distributions and psychometric properties. Arthritis and Rheumatism, 51(3), 350–357.
Carter, G., Lewin, T., Rashid, G., Adams, C., & Clover, K. (2008). Computerised assessment of quality of life in oncology patients and carers. Psychooncology, 17(1), 26–33.
Ginieri-Coccossis, M., Triantafillou, E., Antonopoulou, V., Tomaras, B., & Christodoulou, G. (2001). Quality of life in relation to WHOQOL-100 questionnaire (in Greek). Athens: Beta Medical Arts.
Altman, D. G. (1991). Practical statistics for medical research. London: Chapman and Hall.
Miles, J., & Shevlin, M. (2003). Applying regression and correlation (pp. 165–191). London: Sage.
Creed, F. H., & Dickens, C. (2007). Depression in the medically ill. In A. Steptoe (Ed.), Depression and physical illness (pp. 3–18). Cambridge: Cambridge University Press.
Katon, W., Lin, E. H., & Kroenke, K. (2007). The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. General Hospital Psychiatry, 29(2), 147–155.
Duddu, V., Husain, N., & Dickens, C. (2008). Medically unexplained presentations and quality of life: A study of a predominantly South Asian primary care population in England. Journal of Psychosomatic Research, 65(4), 311–317.
Verkuil, B., Brosschot, J. F., & Thayer, J. F. (2007). A sensitive body or a sensitive mind? Associations among somatic sensitization, cognitive sensitization, health worry, and subjective health complaints. Journal of Psychosomatic Research, 63(6), 673–681.
Bogaerts, K., Millen, A., Li, W., De Peuter, S., Van Diest, I., Vlemincx, E., et al. (2008). High symptom reporters are less interoceptively accurate in a symptom-related context. Journal of Psychosomatic Research, 65(5), 417–424.
Khasabov, S. G., Hamamoto, D. T., Harding-Rose, C., & Simone, D. A. (2007). Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain. Brain Research, 1180, 7–19.
Straub, R. H., Wolff, C., Fassold, A., Hofbauer, R., Chover-Gonzalez, A., Richards, L. J., et al. (2008). Anti-inflammatory role of endorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis. Arthritis Rheumatism, 58(2), 456–466.
Kroenke, K. (2007). Efficacy of treatment for somatoform disorders: A review of randomized controlled trials. Psychosomatic Medicine, 69(9), 881–888.
Creed, F., Tomenson, B., Guthrie, E., Ratcliffe, J., Fernades, L., Rigby, C., Read, N., & Thomson, D. G., (2009). On behalf of the North of Eangland IBS Research Group. Predictors of long term outcome in people with severe irritable syndrome who receive antidepressant or psychological treatment. Alimentary Pharmacology and Therapeutics (Submitted).
Creed, F., Guthrie, E., Ratcliffe, J., Fernandes, L., Rigby, C., Tomenson, B., et al. (2005). Does psychological treatment help only those patients with severe irritable bowel syndrome who also have a concurrent psychiatric disorder? Australian and New Zealand Journal of Psychiatry, 39(9), 807–815.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hyphantis, T., Tomenson, B., Paika, V. et al. Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders. Qual Life Res 18, 1029–1042 (2009). https://doi.org/10.1007/s11136-009-9527-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-009-9527-6